, as a general rule, the survival rates of prostate cancer are very good at a five-year survival rate of 98%.
There is, however, there are a number of factors that can influence survival, especially for men with advanced prostate cancer.They may include:
The progression of the disease
Recycling of the disease
PANUWATDANGSUNGNNOEN / Healem /Reputation
Stage of survival
The prostate cancer stage can be described by doctors using a tumor system, node, metastasis (TNM).The TNM system was developed by the US Cancer Committee. UUUnder this medical system users use scanning and results of diagnostic tests to determine the following values:
tumor (t): How big is the tumor and where is?
node (N): has aDistribution of tumorese Lymphatic nodes, and if so, where is Ikak?
metastasis (m): has cancer, it spreads to other parts of the body, and if so,Where and how much does it spread?
These values are combined to determine the cancer stage on a scale of five scales, from stage 0 (zero) to the fourth stage. This is how it is broken:
In localized prostate cancer, Cancer has not yet spread from the prostate to other parts of the body . It would be equal to Stage I and II through TNM.
In regional prostate cancer Distratious prostate cancer in nearby structures or lymph nodes. This would be equivalent to the stage of TNM III.
In a remote prostate cancer, Cancer spread away from the prostate to other organs, such as liver or lungs. It is equal to step iv on the TNM scale.
The results of prostate cancer are measured using a five-year survival rate. This compares the same types of cancer for those in the general population.
Prostate Cancer 5-Relative survival rates of the year
All stagesProvigations inCombination
Education is based on men diagnosed with prostate cancer between 2009 and 2015.
presentation cancer in the United States
Prostate cancer is the second cause of death associated with cancer between Men in the United States.
Survival in the race
Race can affect survival due to differences in access to care Medical, which can in turn, led the late diagnosis.
Compared with sacred white men, whose people can be diagnosed with prostate cancer and almost 2.5 times more likely to die from prostate cancer.
Blacks have the highest frequency of prostate cancer among all racial / ethnic groups in the United States.
Social inequalities contribute to the worst results for black men with prostate cancer compared to white people. .The same study detected by doctors can underestimate the risk of low quality crabs.
In accordance with the Disease Control and Prevention Centers (CDC), the survival of five years at all stages of prostate cancer It was greater for white men than black or Hispanic men.
Prostate cancer 5-Relative Year Race-Based Survival Indicators
Native Americans Indians / Alaska
Pacific Asia Region
Table> These figures are based on men diagnosed with prostate cancer in the period of 2001 A2016.
Survival by age
Unlike some other cancers, age is less than a prostate cancer cancer.This is partly due to the fact that men will often be diagnosed with prostate cancer after 70 years.
Approximately six out of 10 cases are diagnosed in men who are 65 years old.The average age in the diagnosis is 66, and the diagnosis of up to 40 years is rare.
Exception of this is intended for men with prostate cancer stage IV.In this group, a 10-year mortality rate for prostate cancer is the highest for men aged 60 to 64 years.
Men at age less than 49 years and more than 80 years have the lowest survival rate of 10 years.Those, at age of less than 49, there was 95.6% survival 10 years, while at the age of more than 80 there were 82.7% of the 10-year survival rate.
Survival of progression From the disease
Prostate cancer can affect the survival rate.
, Specific for the prostate antigen gland (PSA) is a protein obtained by the cells of the premature gland with normal and malignant cells. In men with prostate cancer, PSA levels are often being lifted.
Doctors can use PSA as a marker to better understand the progression of prostate cancer and the resulting forecast.
A method of physicians evaluates the progression of the disease through the PSA duplication time.This refers to the number of months, which is required for PSA for dual power.
A study implies a short duplication time means a lower prognosis for patients with stage IV prostate cancer. The average survival was 16 years old.5 months for those who with the duplication time of PSA are below 45 days compared to 26 months for patients with a longer PSA duplication time.
Metasestastic cancer and distributed to other parts of the body outside the prostate, it can also affect survival.In a remote or stage IV of prostate cancer, when cancer spreads from the prostate to other organs, such as liver or light, the rate of five-year survival is 31% compared to localized cancer ( Stage I and II),which has a five-year survival rate at almost 100%.
, when the prostate cancer is usually diagnosed.
Around 92% of prostate cancer is diagnosed in early stages (localized or regional).
Survival in the evaluation of the tumor
Unilateral cancer is supplied, look at the degree of cancer. The evaluation refers to how the cancer cells are seen under the microscope.
Traditionally, for prostate cancer, this was done using the Gleason score, which was developed in the 1960s. With this system, cancer cells are classified on a scale of 1 to 5.Class 1 cells are considered normal tissues of the prostate gland, while the cells in the range of 5 are mutated to such a point that are no longer similar to normal cells.
When determining the Gleason score, the pathologist will verify the biopsy sample under the microscope and gives the Glesss class using the scale mentioned above to the most predominant image, which is the second most predominant.Then, these two varieties are added to form a common Glason score (for example, 3 grade + at 4 class = A 7 at glue points).
Theory, the closure indicators may vary from 2 to 10, but nowadays the pathologists rarely rarely give an account of 2 to 5 and, most likely, will be in the range of 6 a 10 S 6, the lowest level of prostate cancer.
As part of the Gleason account system, it is considered a 6 of a low class, 7 is an intermediate compound and scores 8, 9, or 10 are considered high quality cancers.
The greater the Gleason estimate, it is more likely that prostate cancer will grow and spread rapidly.However, there were some problems with the Glies System, and the new evaluation system was developed, acted as the expansion of the Glies System.
According to this Gleuse ball system, they are now classified into class groups:
Class group 1 = Gleses 6 (or less)
Class group 2 = Glizone 3 + 4 = 7
Class 3 = Gleason 4 + 3 = 7
Class 4 = Gesase 8
Class 5 = GLSEASON 9-10
According to the American Cancer Society, this system can eventually replace the GLISHS system, but currently communicating together.
Survival in recurrence of disease
If a man is developing a high psa level (more than 0.2 ml) after the operation of cancer, the disease is considered a recurrent .
The number of lymph nodes during prostatectomy can affect the risk of recurrence.However, the study suggests that the elimination of a large number of nodes is associated with the improvement of the probability of recurrence, but this does not affect overall survival.
But the recurrence of diseases does not always affect survival. If there is a relapse, the survival rate of 15 years at the time of diagnosis can reach 94% in those with respect to low risk relapse.
Main factors that affect survival rates:
Time by bending PSA
If recurrence occurs within three years or after three years
Relapse, what happens for three years, reduces survival of survival from 15 to 20% and even more if duplication time is short.
as usual, the recurrence of prostate cancer?
Between 20 and 30% of men with prostate cancer will be resorted at some point after treatment.
Smoking is a factor that affects survival rates in almost all cancer, including cancer of prostateCurrent smokers have a poorest chance of survival of prostate cancer, and recurrence that nezmochers. .
Word get Meds information
The general survival rate of prostate cancer is good, with a five-year survival rate of 98%.Even with the IV stage improvement of prostate cancer in the treatment, the time of survival and led to a significant decrease in deaths from prostate cancer.